secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aridis Pharmaceuticals, Inc. (—)
CIK:        0001614067
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001493152-23-022159
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Aridis Pharmaceuticals appoints Grassi & Co. as new auditor after Baker Tilly resignation
--------------------------------------------------------------------------------

- Baker Tilly resigned as independent auditor effective after filing Q1 2023 10-Q.
- Grassi & Co. appointed as new independent registered public accounting firm effective June 16, 2023.
- Audit Committee approved the appointment; no prior consultations with Grassi on accounting matters.
- No disagreements or reportable events occurred with former auditor during 2022 or Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223022159/0001493152-23-022159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223022159/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer